Rob Califf returns to lead the FDA as the U.S. continues to cope with the pandemic and opioid epidemic. The agency also is facing questions about its processes for accelerated drug approvals.
Biden’s FDA Chief Nominee Narrowly Wins Senate Confirmation
by Devops | Feb 16, 2022 | Medical News | 0 comments

Recent Comments